nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—CYP1A2—chronic obstructive pulmonary disease	0.375	1	CbGaD
Pantoprazole—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0435	0.118	CbGbCtD
Pantoprazole—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0435	0.118	CbGbCtD
Pantoprazole—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0362	0.0983	CbGbCtD
Pantoprazole—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0362	0.0983	CbGbCtD
Pantoprazole—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0341	0.0927	CbGbCtD
Pantoprazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0278	0.0754	CbGbCtD
Pantoprazole—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0274	0.0745	CbGbCtD
Pantoprazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0187	0.0509	CbGbCtD
Pantoprazole—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0183	0.0496	CbGbCtD
Pantoprazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0179	0.0486	CbGbCtD
Pantoprazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0159	0.0433	CbGbCtD
Pantoprazole—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0156	0.0424	CbGbCtD
Pantoprazole—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0147	0.0401	CbGbCtD
Pantoprazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00935	0.0254	CbGbCtD
Pantoprazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00883	0.024	CbGbCtD
Pantoprazole—Rabeprazole—CYP1A1—chronic obstructive pulmonary disease	0.000877	0.199	CrCbGaD
Pantoprazole—Rabeprazole—CYP1A2—chronic obstructive pulmonary disease	0.000846	0.192	CrCbGaD
Pantoprazole—Omeprazole—CYP1A1—chronic obstructive pulmonary disease	0.000715	0.162	CrCbGaD
Pantoprazole—Omeprazole—CYP1A2—chronic obstructive pulmonary disease	0.000689	0.156	CrCbGaD
Pantoprazole—Lansoprazole—CYP1A1—chronic obstructive pulmonary disease	0.000654	0.148	CrCbGaD
Pantoprazole—Lansoprazole—CYP1A2—chronic obstructive pulmonary disease	0.00063	0.143	CrCbGaD
Pantoprazole—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00018	0.00298	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000177	0.00293	CbGpPWpGaD
Pantoprazole—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000172	0.00285	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000171	0.00282	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000171	0.00282	CbGpPWpGaD
Pantoprazole—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00282	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000167	0.00277	CbGpPWpGaD
Pantoprazole—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000161	0.00266	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000158	0.00261	CbGpPWpGaD
Pantoprazole—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.0026	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000157	0.0026	CbGpPWpGaD
Pantoprazole—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00259	CbGpPWpGaD
Pantoprazole—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000152	0.00252	CbGpPWpGaD
Pantoprazole—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.0025	CbGpPWpGaD
Pantoprazole—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00249	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000149	0.00246	CbGpPWpGaD
Pantoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.00246	CbGpPWpGaD
Pantoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00243	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000146	0.00242	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000144	0.00238	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000143	0.00236	CbGpPWpGaD
Pantoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.00233	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000139	0.0023	CbGpPWpGaD
Pantoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00225	CbGpPWpGaD
Pantoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.00222	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000133	0.000691	CcSEcCtD
Pantoprazole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000687	CcSEcCtD
Pantoprazole—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000686	CcSEcCtD
Pantoprazole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000132	0.000685	CcSEcCtD
Pantoprazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000132	0.000684	CcSEcCtD
Pantoprazole—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000684	CcSEcCtD
Pantoprazole—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000132	0.00218	CbGpPWpGaD
Pantoprazole—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000683	CcSEcCtD
Pantoprazole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000679	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00013	0.00216	CbGpPWpGaD
Pantoprazole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000674	CcSEcCtD
Pantoprazole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000674	CcSEcCtD
Pantoprazole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000669	CcSEcCtD
Pantoprazole—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000667	CcSEcCtD
Pantoprazole—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000667	CcSEcCtD
Pantoprazole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000666	CcSEcCtD
Pantoprazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.000663	CcSEcCtD
Pantoprazole—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000663	CcSEcCtD
Pantoprazole—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000662	CcSEcCtD
Pantoprazole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000661	CcSEcCtD
Pantoprazole—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00066	CcSEcCtD
Pantoprazole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000657	CcSEcCtD
Pantoprazole—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000657	CcSEcCtD
Pantoprazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000654	CcSEcCtD
Pantoprazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.000651	CcSEcCtD
Pantoprazole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000651	CcSEcCtD
Pantoprazole—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.00207	CbGpPWpGaD
Pantoprazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00065	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00065	CcSEcCtD
Pantoprazole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000645	CcSEcCtD
Pantoprazole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000645	CcSEcCtD
Pantoprazole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000642	CcSEcCtD
Pantoprazole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000123	0.000641	CcSEcCtD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000123	0.00204	CbGpPWpGaD
Pantoprazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000637	CcSEcCtD
Pantoprazole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000636	CcSEcCtD
Pantoprazole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000636	CcSEcCtD
Pantoprazole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000634	CcSEcCtD
Pantoprazole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000634	CcSEcCtD
Pantoprazole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000632	CcSEcCtD
Pantoprazole—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00063	CcSEcCtD
Pantoprazole—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000629	CcSEcCtD
Pantoprazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000628	CcSEcCtD
Pantoprazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000628	CcSEcCtD
Pantoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.002	CbGpPWpGaD
Pantoprazole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000627	CcSEcCtD
Pantoprazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00012	0.000625	CcSEcCtD
Pantoprazole—Injury—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000621	CcSEcCtD
Pantoprazole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000621	CcSEcCtD
Pantoprazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.00062	CcSEcCtD
Pantoprazole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000618	CcSEcCtD
Pantoprazole—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000119	0.00196	CbGpPWpGaD
Pantoprazole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000616	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000616	CcSEcCtD
Pantoprazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000615	CcSEcCtD
Pantoprazole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000615	CcSEcCtD
Pantoprazole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000615	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000614	CcSEcCtD
Pantoprazole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.00061	CcSEcCtD
Pantoprazole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.00061	CcSEcCtD
Pantoprazole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000117	0.00061	CcSEcCtD
Pantoprazole—Pain—Formoterol—chronic obstructive pulmonary disease	0.000117	0.00061	CcSEcCtD
Pantoprazole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000609	CcSEcCtD
Pantoprazole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000608	CcSEcCtD
Pantoprazole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000605	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000603	CcSEcCtD
Pantoprazole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000602	CcSEcCtD
Pantoprazole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.0006	CcSEcCtD
Pantoprazole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000599	CcSEcCtD
Pantoprazole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000597	CcSEcCtD
Pantoprazole—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000597	CcSEcCtD
Pantoprazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000115	0.000596	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000594	CcSEcCtD
Pantoprazole—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000594	CcSEcCtD
Pantoprazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00189	CbGpPWpGaD
Pantoprazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000593	CcSEcCtD
Pantoprazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000114	0.000591	CcSEcCtD
Pantoprazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000114	0.00059	CcSEcCtD
Pantoprazole—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000589	CcSEcCtD
Pantoprazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000588	CcSEcCtD
Pantoprazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000588	CcSEcCtD
Pantoprazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000113	0.000587	CcSEcCtD
Pantoprazole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000585	CcSEcCtD
Pantoprazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.000584	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000583	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000583	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000581	CcSEcCtD
Pantoprazole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000581	CcSEcCtD
Pantoprazole—ABCG2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000112	0.00185	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000111	0.00183	CbGpPWpGaD
Pantoprazole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000576	CcSEcCtD
Pantoprazole—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000576	CcSEcCtD
Pantoprazole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00183	CbGpPWpGaD
Pantoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00182	CbGpPWpGaD
Pantoprazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000571	CcSEcCtD
Pantoprazole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000571	CcSEcCtD
Pantoprazole—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000571	CcSEcCtD
Pantoprazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000567	CcSEcCtD
Pantoprazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000567	CcSEcCtD
Pantoprazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000564	CcSEcCtD
Pantoprazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000564	CcSEcCtD
Pantoprazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000564	CcSEcCtD
Pantoprazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000564	CcSEcCtD
Pantoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00179	CbGpPWpGaD
Pantoprazole—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000562	CcSEcCtD
Pantoprazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000108	0.000562	CcSEcCtD
Pantoprazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000107	0.000557	CcSEcCtD
Pantoprazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000107	0.000557	CcSEcCtD
Pantoprazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000107	0.000557	CcSEcCtD
Pantoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00177	CbGpPWpGaD
Pantoprazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000555	CcSEcCtD
Pantoprazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000555	CcSEcCtD
Pantoprazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000106	0.000554	CcSEcCtD
Pantoprazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000552	CcSEcCtD
Pantoprazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000552	CcSEcCtD
Pantoprazole—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000551	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000551	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000106	0.00175	CbGpPWpGaD
Pantoprazole—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000547	CcSEcCtD
Pantoprazole—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000544	CcSEcCtD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000104	0.00173	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00173	CbGpPWpGaD
Pantoprazole—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00173	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00173	CbGpPWpGaD
Pantoprazole—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000541	CcSEcCtD
Pantoprazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000535	CcSEcCtD
Pantoprazole—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000103	0.0017	CbGpPWpGaD
Pantoprazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000532	CcSEcCtD
Pantoprazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000532	CcSEcCtD
Pantoprazole—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000102	0.00168	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000526	CcSEcCtD
Pantoprazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000526	CcSEcCtD
Pantoprazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000101	0.000525	CcSEcCtD
Pantoprazole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000524	CcSEcCtD
Pantoprazole—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000524	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.0001	0.00166	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	9.9e-05	0.000515	CcSEcCtD
Pantoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.87e-05	0.00163	CbGpPWpGaD
Pantoprazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	9.84e-05	0.000512	CcSEcCtD
Pantoprazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	9.84e-05	0.000512	CcSEcCtD
Pantoprazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.75e-05	0.00161	CbGpPWpGaD
Pantoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.74e-05	0.00161	CbGpPWpGaD
Pantoprazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	9.71e-05	0.000505	CcSEcCtD
Pantoprazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	9.71e-05	0.000505	CcSEcCtD
Pantoprazole—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.000504	CcSEcCtD
Pantoprazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	9.64e-05	0.000501	CcSEcCtD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	9.58e-05	0.00159	CbGpPWpGaD
Pantoprazole—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.000497	CcSEcCtD
Pantoprazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.54e-05	0.000496	CcSEcCtD
Pantoprazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.51e-05	0.000494	CcSEcCtD
Pantoprazole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	9.39e-05	0.000488	CcSEcCtD
Pantoprazole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	9.39e-05	0.000488	CcSEcCtD
Pantoprazole—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	9.34e-05	0.000486	CcSEcCtD
Pantoprazole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000484	CcSEcCtD
Pantoprazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	9.29e-05	0.000483	CcSEcCtD
Pantoprazole—Sweating increased—Prednisone—chronic obstructive pulmonary disease	9.25e-05	0.000481	CcSEcCtD
Pantoprazole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	9.19e-05	0.000478	CcSEcCtD
Pantoprazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	9.16e-05	0.000477	CcSEcCtD
Pantoprazole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.16e-05	0.00152	CbGpPWpGaD
Pantoprazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	9.07e-05	0.000472	CcSEcCtD
Pantoprazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	9.07e-05	0.000472	CcSEcCtD
Pantoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.96e-05	0.00148	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.95e-05	0.00148	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	8.94e-05	0.00148	CbGpPWpGaD
Pantoprazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	8.89e-05	0.000462	CcSEcCtD
Pantoprazole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	8.86e-05	0.000461	CcSEcCtD
Pantoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.84e-05	0.00146	CbGpPWpGaD
Pantoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.77e-05	0.00145	CbGpPWpGaD
Pantoprazole—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	8.74e-05	0.000455	CcSEcCtD
Pantoprazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	8.72e-05	0.000454	CcSEcCtD
Pantoprazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	8.72e-05	0.000454	CcSEcCtD
Pantoprazole—Rash—Formoterol—chronic obstructive pulmonary disease	8.65e-05	0.00045	CcSEcCtD
Pantoprazole—Rash—Arformoterol—chronic obstructive pulmonary disease	8.65e-05	0.00045	CcSEcCtD
Pantoprazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.64e-05	0.000449	CcSEcCtD
Pantoprazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.64e-05	0.000449	CcSEcCtD
Pantoprazole—Weight increased—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000449	CcSEcCtD
Pantoprazole—Headache—Formoterol—chronic obstructive pulmonary disease	8.59e-05	0.000447	CcSEcCtD
Pantoprazole—Headache—Arformoterol—chronic obstructive pulmonary disease	8.59e-05	0.000447	CcSEcCtD
Pantoprazole—Weight decreased—Prednisone—chronic obstructive pulmonary disease	8.59e-05	0.000447	CcSEcCtD
Pantoprazole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	8.58e-05	0.000446	CcSEcCtD
Pantoprazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.57e-05	0.000445	CcSEcCtD
Pantoprazole—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000445	CcSEcCtD
Pantoprazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.54e-05	0.000444	CcSEcCtD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	8.54e-05	0.00141	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	8.49e-05	0.00141	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.48e-05	0.0014	CbGpPWpGaD
Pantoprazole—Rash—Montelukast—chronic obstructive pulmonary disease	8.47e-05	0.000441	CcSEcCtD
Pantoprazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.46e-05	0.00044	CcSEcCtD
Pantoprazole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	8.45e-05	0.000439	CcSEcCtD
Pantoprazole—Depression—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000439	CcSEcCtD
Pantoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.43e-05	0.00139	CbGpPWpGaD
Pantoprazole—Headache—Montelukast—chronic obstructive pulmonary disease	8.42e-05	0.000438	CcSEcCtD
Pantoprazole—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.000434	CcSEcCtD
Pantoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.32e-05	0.00138	CbGpPWpGaD
Pantoprazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	8.32e-05	0.000433	CcSEcCtD
Pantoprazole—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.000431	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.000431	CcSEcCtD
Pantoprazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	8.24e-05	0.000428	CcSEcCtD
Pantoprazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	8.21e-05	0.000427	CcSEcCtD
Pantoprazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	8.18e-05	0.000425	CcSEcCtD
Pantoprazole—Rash—Salbutamol—chronic obstructive pulmonary disease	8.17e-05	0.000425	CcSEcCtD
Pantoprazole—Syncope—Prednisolone—chronic obstructive pulmonary disease	8.16e-05	0.000424	CcSEcCtD
Pantoprazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.16e-05	0.000424	CcSEcCtD
Pantoprazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	8.15e-05	0.000424	CcSEcCtD
Pantoprazole—Nausea—Formoterol—chronic obstructive pulmonary disease	8.15e-05	0.000424	CcSEcCtD
Pantoprazole—Headache—Salbutamol—chronic obstructive pulmonary disease	8.12e-05	0.000422	CcSEcCtD
Pantoprazole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.05e-05	0.00133	CbGpPWpGaD
Pantoprazole—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	8e-05	0.000416	CcSEcCtD
Pantoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8e-05	0.00132	CbGpPWpGaD
Pantoprazole—Nausea—Montelukast—chronic obstructive pulmonary disease	7.98e-05	0.000415	CcSEcCtD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	7.91e-05	0.00131	CbGpPWpGaD
Pantoprazole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	7.89e-05	0.00041	CcSEcCtD
Pantoprazole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	7.86e-05	0.000409	CcSEcCtD
Pantoprazole—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.72e-05	0.00128	CbGpPWpGaD
Pantoprazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.69e-05	0.0004	CcSEcCtD
Pantoprazole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	7.66e-05	0.000398	CcSEcCtD
Pantoprazole—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	7.64e-05	0.000397	CcSEcCtD
Pantoprazole—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.63e-05	0.00126	CbGpPWpGaD
Pantoprazole—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	7.6e-05	0.000395	CcSEcCtD
Pantoprazole—Hallucination—Prednisone—chronic obstructive pulmonary disease	7.56e-05	0.000393	CcSEcCtD
Pantoprazole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.000388	CcSEcCtD
Pantoprazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	7.43e-05	0.000386	CcSEcCtD
Pantoprazole—Oedema—Prednisolone—chronic obstructive pulmonary disease	7.43e-05	0.000386	CcSEcCtD
Pantoprazole—Shock—Prednisolone—chronic obstructive pulmonary disease	7.31e-05	0.00038	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	7.31e-05	0.00121	CbGpPWpGaD
Pantoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.26e-05	0.0012	CbGpPWpGaD
Pantoprazole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	7.25e-05	0.000377	CcSEcCtD
Pantoprazole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.18e-05	0.000373	CcSEcCtD
Pantoprazole—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.12e-05	0.00118	CbGpPWpGaD
Pantoprazole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	7.1e-05	0.000369	CcSEcCtD
Pantoprazole—Flushing—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000367	CcSEcCtD
Pantoprazole—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.04e-05	0.00116	CbGpPWpGaD
Pantoprazole—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.95e-05	0.00115	CbGpPWpGaD
Pantoprazole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	6.86e-05	0.000357	CcSEcCtD
Pantoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.83e-05	0.00113	CbGpPWpGaD
Pantoprazole—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.79e-05	0.000353	CcSEcCtD
Pantoprazole—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	6.77e-05	0.00112	CbGpPWpGaD
Pantoprazole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.72e-05	0.000349	CcSEcCtD
Pantoprazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000349	CcSEcCtD
Pantoprazole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.67e-05	0.000347	CcSEcCtD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	6.66e-05	0.0011	CbGpPWpGaD
Pantoprazole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000346	CcSEcCtD
Pantoprazole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.000344	CcSEcCtD
Pantoprazole—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.55e-05	0.00108	CbGpPWpGaD
Pantoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.51e-05	0.00108	CbGpPWpGaD
Pantoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.42e-05	0.00106	CbGpPWpGaD
Pantoprazole—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.41e-05	0.00106	CbGpPWpGaD
Pantoprazole—Pain—Prednisolone—chronic obstructive pulmonary disease	6.35e-05	0.00033	CcSEcCtD
Pantoprazole—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.32e-05	0.00105	CbGpPWpGaD
Pantoprazole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000324	CcSEcCtD
Pantoprazole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000319	CcSEcCtD
Pantoprazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.12e-05	0.000318	CcSEcCtD
Pantoprazole—Anaemia—Prednisone—chronic obstructive pulmonary disease	6.11e-05	0.000318	CcSEcCtD
Pantoprazole—Agitation—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000316	CcSEcCtD
Pantoprazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.000314	CcSEcCtD
Pantoprazole—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.01e-05	0.000995	CbGpPWpGaD
Pantoprazole—Malaise—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.00031	CcSEcCtD
Pantoprazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.94e-05	0.000309	CcSEcCtD
Pantoprazole—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.94e-05	0.000983	CbGpPWpGaD
Pantoprazole—Syncope—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000308	CcSEcCtD
Pantoprazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.9e-05	0.000307	CcSEcCtD
Pantoprazole—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.85e-05	0.000967	CbGpPWpGaD
Pantoprazole—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000302	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.77e-05	0.000955	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.77e-05	0.000954	CbGpPWpGaD
Pantoprazole—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.000298	CcSEcCtD
Pantoprazole—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.71e-05	0.000297	CcSEcCtD
Pantoprazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.63e-05	0.000293	CcSEcCtD
Pantoprazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.63e-05	0.000293	CcSEcCtD
Pantoprazole—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.000292	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000291	CcSEcCtD
Pantoprazole—Discomfort—Prednisone—chronic obstructive pulmonary disease	5.56e-05	0.000289	CcSEcCtD
Pantoprazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.47e-05	0.000285	CcSEcCtD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.42e-05	0.000897	CbGpPWpGaD
Pantoprazole—Oedema—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000281	CcSEcCtD
Pantoprazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000281	CcSEcCtD
Pantoprazole—Infection—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000279	CcSEcCtD
Pantoprazole—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.35e-05	0.000885	CbGpPWpGaD
Pantoprazole—Shock—Prednisone—chronic obstructive pulmonary disease	5.31e-05	0.000276	CcSEcCtD
Pantoprazole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.29e-05	0.000275	CcSEcCtD
Pantoprazole—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.28e-05	0.000873	CbGpPWpGaD
Pantoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.27e-05	0.000873	CbGpPWpGaD
Pantoprazole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.27e-05	0.000274	CcSEcCtD
Pantoprazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.24e-05	0.000273	CcSEcCtD
Pantoprazole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000271	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.21e-05	0.000862	CbGpPWpGaD
Pantoprazole—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.15e-05	0.000268	CcSEcCtD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.95e-05	0.000818	CbGpPWpGaD
Pantoprazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000256	CcSEcCtD
Pantoprazole—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.92e-05	0.000813	CbGpPWpGaD
Pantoprazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.91e-05	0.000255	CcSEcCtD
Pantoprazole—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.89e-05	0.000809	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.88e-05	0.000808	CbGpPWpGaD
Pantoprazole—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000254	CcSEcCtD
Pantoprazole—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.88e-05	0.000807	CbGpPWpGaD
Pantoprazole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.000252	CcSEcCtD
Pantoprazole—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.85e-05	0.000802	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.84e-05	0.000801	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.81e-05	0.000796	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.8e-05	0.000794	CbGpPWpGaD
Pantoprazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000247	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	4.71e-05	0.000779	CbGpPWpGaD
Pantoprazole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000244	CcSEcCtD
Pantoprazole—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.69e-05	0.000776	CbGpPWpGaD
Pantoprazole—Rash—Prednisolone—chronic obstructive pulmonary disease	4.68e-05	0.000244	CcSEcCtD
Pantoprazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.68e-05	0.000243	CcSEcCtD
Pantoprazole—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.66e-05	0.000771	CbGpPWpGaD
Pantoprazole—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000242	CcSEcCtD
Pantoprazole—Headache—Prednisolone—chronic obstructive pulmonary disease	4.65e-05	0.000242	CcSEcCtD
Pantoprazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.64e-05	0.000768	CbGpPWpGaD
Pantoprazole—Constipation—Prednisone—chronic obstructive pulmonary disease	4.62e-05	0.00024	CcSEcCtD
Pantoprazole—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.6e-05	0.00076	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.59e-05	0.000759	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.58e-05	0.000758	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.48e-05	0.000742	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.48e-05	0.000742	CbGpPWpGaD
Pantoprazole—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.48e-05	0.000742	CbGpPWpGaD
Pantoprazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.45e-05	0.000231	CcSEcCtD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.44e-05	0.000734	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.42e-05	0.000731	CbGpPWpGaD
Pantoprazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.00023	CcSEcCtD
Pantoprazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.41e-05	0.000229	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.4e-05	0.000727	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.4e-05	0.000727	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.38e-05	0.000724	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	4.36e-05	0.000722	CbGpPWpGaD
Pantoprazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.29e-05	0.000223	CcSEcCtD
Pantoprazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.000222	CcSEcCtD
Pantoprazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.000222	CcSEcCtD
Pantoprazole—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.25e-05	0.000703	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.23e-05	0.000699	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.19e-05	0.000693	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.19e-05	0.000693	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.19e-05	0.000693	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.17e-05	0.00069	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.11e-05	0.00068	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.05e-05	0.000671	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.98e-05	0.000207	CcSEcCtD
Pantoprazole—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.97e-05	0.000657	CbGpPWpGaD
Pantoprazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000201	CcSEcCtD
Pantoprazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.86e-05	0.000638	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.83e-05	0.000634	CbGpPWpGaD
Pantoprazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.82e-05	0.000199	CcSEcCtD
Pantoprazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.8e-05	0.000629	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.78e-05	0.000625	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.76e-05	0.000621	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.75e-05	0.00062	CbGpPWpGaD
Pantoprazole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.69e-05	0.000192	CcSEcCtD
Pantoprazole—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.66e-05	0.000605	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.64e-05	0.000603	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.63e-05	0.000601	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.58e-05	0.000592	CbGpPWpGaD
Pantoprazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.57e-05	0.000186	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.49e-05	0.000577	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.48e-05	0.000575	CbGpPWpGaD
Pantoprazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.43e-05	0.000178	CcSEcCtD
Pantoprazole—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.42e-05	0.000566	CbGpPWpGaD
Pantoprazole—Rash—Prednisone—chronic obstructive pulmonary disease	3.4e-05	0.000177	CcSEcCtD
Pantoprazole—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.4e-05	0.000563	CbGpPWpGaD
Pantoprazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.4e-05	0.000177	CcSEcCtD
Pantoprazole—Headache—Prednisone—chronic obstructive pulmonary disease	3.38e-05	0.000176	CcSEcCtD
Pantoprazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.22e-05	0.000532	CbGpPWpGaD
Pantoprazole—Nausea—Prednisone—chronic obstructive pulmonary disease	3.21e-05	0.000167	CcSEcCtD
Pantoprazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.17e-05	0.000525	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.96e-05	0.000489	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.92e-05	0.000483	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.92e-05	0.000482	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.8e-05	0.000464	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.000457	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.67e-05	0.000442	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.57e-05	0.000426	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.54e-05	0.000421	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.48e-05	0.000411	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.46e-05	0.000407	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.44e-05	0.000403	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.42e-05	0.000401	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.42e-05	0.0004	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.38e-05	0.000394	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.37e-05	0.000392	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.36e-05	0.00039	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.35e-05	0.00039	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.32e-05	0.000384	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.26e-05	0.000375	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.25e-05	0.000373	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.25e-05	0.000373	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.25e-05	0.000372	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.25e-05	0.000372	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.2e-05	0.000364	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.19e-05	0.000363	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.15e-05	0.000356	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.000354	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.09e-05	0.000345	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.08e-05	0.000345	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.05e-05	0.000339	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.98e-05	0.000328	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.96e-05	0.000324	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.93e-05	0.00032	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.88e-05	0.000311	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.88e-05	0.000311	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.8e-05	0.000298	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000296	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.78e-05	0.000295	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.76e-05	0.000292	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.76e-05	0.000291	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.75e-05	0.00029	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.68e-05	0.000278	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.65e-05	0.000273	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.64e-05	0.000271	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.00027	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.63e-05	0.000269	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000257	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.52e-05	0.000251	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.49e-05	0.000247	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.48e-05	0.000245	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.45e-05	0.00024	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000238	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.39e-05	0.000231	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.35e-05	0.000223	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.32e-05	0.000218	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.3e-05	0.000216	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.29e-05	0.000213	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.27e-05	0.000211	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.22e-05	0.000201	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000199	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.19e-05	0.000197	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000197	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000192	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.13e-05	0.000187	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000183	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000181	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.00018	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.07e-05	0.000177	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000175	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.00017	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000168	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.000167	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1e-05	0.000165	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	9.78e-06	0.000162	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.48e-06	0.000157	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.35e-06	0.000155	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.27e-06	0.000153	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.15e-06	0.000151	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.02e-06	0.000149	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.93e-06	0.000148	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.8e-06	0.000146	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.41e-06	0.000139	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.34e-06	0.000138	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.23e-06	0.000136	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.2e-06	0.000136	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.97e-06	0.000132	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.94e-06	0.000131	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.84e-06	0.00013	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.78e-06	0.000129	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.66e-06	0.000127	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.27e-06	0.00012	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.16e-06	0.000118	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.13e-06	0.000118	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.03e-06	0.000116	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.59e-06	0.000109	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.55e-06	0.000108	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.21e-06	0.000103	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.5e-06	9.1e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.42e-06	8.98e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.42e-06	8.96e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.29e-06	8.75e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.18e-06	8.57e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.06e-06	8.37e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.05e-06	8.36e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.94e-06	8.17e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.79e-06	7.93e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.72e-06	7.82e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.22e-06	6.98e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.04e-06	6.68e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.26e-06	5.39e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.12e-06	5.16e-05	CbGpPWpGaD
